Amarillo doctor explains new procedure that offers hope for COPD patients
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
manilatimes22 小时
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...